BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Zimmer (ZMH) Celebrates 15 Years of Advanced Orthopaedic Implant Technology


10/11/2012 12:26:11 PM

WARSAW, Ind., Oct. 10, 2012 /PRNewswire/ -- Zimmer, Inc., a global leader in musculoskeletal health, today celebrated 15 years of clinical history of its Trabecular MetalTechnology at its dedicated facility in Parsippany, New Jersey. Trabecular Metal Technology is a core platform technology for Zimmer, helping the Company restore mobility and alleviate pain for millions of people around the world.

"Trabecular Metal Technology is among the greatest innovations in orthopaedics in the last 15 years. No other porous metal material so closely resembles the structure, function and physiology of trabecular bone. That is why Trabecular Metal Technology continues to set the standard in the industry," said Jeff McCaulley, President, Zimmer Reconstructive. "Trabecular Metal Material features unmatched porosity, which helps living tissue and bone grow onto and into joint replacements and implants."

Since its introduction in 1997, Trabecular Metal Technology has been used in more than 800,000 surgeries worldwide. The technology has been featured in more than 240 clinical publications and countless surgeons have adopted it for use with their patients. Over the past 15 years, applications of Trabecular Metal Technology have grown steadily. Trabecular Metal Technology is now used in knee, hip and shoulder replacements, trauma applications, spine implants, dental implants and bone void fillers and augments used in oncology.

Zimmer's Parsippany Trabecular Metal Technology facility is 115,000 square feet, boasts 230 employees and runs 24/7. In addition to manufacturing, it hosts a Zimmer Institute training center, providing medical education and training to hundreds of surgeons and dental clinicians each year.

About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2011 sales were approximately $4.5 billion. The Company is supported by the efforts of more than 8,500 employees worldwide.

Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.

SOURCE Zimmer, Inc.



Read at BioSpace.com

Zimmer
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->